Login/Register
  • 中文
  • English

News

TaiGen Biopharmaceuticals Partners with Insilico Medicine for AI-Driven CKD Anemia Drug

TaiGen Biotechnology has signed an exclusive licensing agreement with Insilico Medicine to develop and commercialize ISM4808, a potential best-in-class PHD inhibitor for treating Chronic Kidney Disease (CKD) anemia.

Read more
Dec 12, 2025
TaiGen’s Pixavir Fluromarboxil Approved in China; Targets RMB 10 Billion Market
Dec 12, 2025
TSH Biopharm Aims to Double Annual Revenue via Four Strategic Engines
Dec 12, 2025
CHC Healthcare Group Sees Strong Q4 Performance Driven by Equipment Cycles
Dec 12, 2025
Lotus Pharmaceutical Reports 14% Growth in Asian Operations Despite FX Headwinds
Dec 11, 2025
Super-Aged Society: Focus on AI to Drive "Healthy Taiwan"
Dec 11, 2025
Localization of BNCT: Heron Neutron Medical Partners with Canada’s ACSI for Technology Transfer
Dec 11, 2025
Milestone Payment Secured as Licensing Partner Completes GMP Validation for Anya Biopharm
Dec 10, 2025
Microsoft Fabric Integrates with Local Data Centers; TBMC Builds Real-World Data Platform
Dec 10, 2025
PharmaEssentia Completes First FDA Meeting for ET; On Track for 2026 Approval

Most Watched

Recommended

Anscare Arterial Hemostat
Sung En Group
BR-FHUS Smart System
TaiHao Medical Inc
(2023)Smart Mattress Pressure Sensing System
Taipei Medical University and Healthcare System

Industry Watch

Read more